Can Eyelid Lesion Removal Be Billed to Insurance?
Understanding insurance coverage when treating eyelid lesions.
Is eyelid lesion removal covered by insurance? It's one of the most common questions we hear from eye care professionals considering adding in-office lesion removal to their practices.
In many cases, the answer is yes. Eyelid lesion removal can be billed to insurance when it is considered medically necessary and when the appropriate documentation is in place. When a benign eyelid lesion is removed for a documented medical reason, the procedure may be covered by insurance, including Medicare, in much the same way as other medically necessary skin procedures.
For practices already seeing these patients, it often becomes a natural extension of care. You're treating the patient in the office, and in certain situations, the procedure may also qualify for reimbursement, depending on the carrier and clinical presentation.
When does insurance cover eyelid lesion removal?
Coverage really comes down to one thing: medical necessity. If the lesion is being removed purely for cosmetic reasons, it is treated like other cosmetic procedures and usually will not be covered, including by Medicare, and the patient is financially responsible. For Medicare patients, an Advance Beneficiary Notice sets that expectation in writing before the procedure. Medicare and most payers follow published guidance, such as a local coverage determination for the removal of benign skin lesions, that lists the clinical conditions making a removal medically necessary rather than cosmetic. If it is causing symptoms or functional issues, there is a much stronger case for reimbursement.
Situations that often support medical necessity include lesions that:
- Cause bleeding, itching, or pain
- Cause irritation, discomfort, or ongoing inflammation
- Interfere with blinking or normal eyelid function
- Impact the visual field
- Lead to recurrent irritation or infection
- Show noticeable changes in size, shape, or appearance that warrant clinical attention
Common lesions that fall into this category include:
- Papilloma
- Seborrheic keratosis
- Verruca (wart)
- Xanthelasma (case dependent)
- Molluscum
- Skin tags and other benign eyelid growths
Because these are medical procedures, they are billed to the patient's medical insurance rather than a vision plan, an important distinction for optometric practices. Some payers occasionally require prior authorization before the procedure, so it is worth verifying each patient's plan in advance.
Every payer is different, so coverage still ultimately depends on the patient's plan and how the case is documented.
Documentation is usually what decides the claim
If there is one area practices underestimate, it's documentation.
Even when a procedure is clearly medically necessary, claims can still be denied if the clinical story is not well supported.
At a minimum, most practices should be documenting:
- Patient symptoms and what brought them in
- Clinical findings and exam details
- Size, location, and appearance of the lesion
- How is it affecting function or comfort
- Why removal is medically necessary
- Photos when appropriate
- Procedure details, including an operative or procedure note, and follow-up plan
The stronger and more consistent this is, the easier it becomes to support reimbursement if questioned.
Coding and CPT considerations
There is no single “standard” for coding eyelid lesion removal across all situations. It varies based on the lesion, diagnosis, payer, and technique used.
The CPT code most commonly associated with chemical cautery of benign eyelid lesions is 67850. In certain situations, 17110 may also be considered when the procedure involves the destruction of benign lesions rather than surgical excision. As with any procedure, the CPT code must be paired with an appropriate ICD-10 diagnosis code that supports medical necessity. In situations where a significant, separately identifiable evaluation and management service is performed on the same day as the procedure, an office visit may also be reported using modifier 25. Because these are considered minor procedures with a short global period, routine postoperative care is typically included in the procedure reimbursement.
Things that typically influence coding include:
- Number of lesions treated in a visit
- Type and classification of the lesion
- Exact location on the eyelid or periocular area
- Method used for removal
- Whether pathology is required
Because these guidelines can change and vary by payer, most practices confirm the exact CPT code, diagnosis code, and any modifiers with their billing team or coding resources before submitting claims.
Why many practices add this service
Beyond the clinical benefit, adding in-office lesion removal tends to create a few practical advantages.
Easier for patients
Most patients prefer staying within their existing eye care provider's office rather than being referred out for a minor procedure.
More complete care in-house
It allows providers to manage common eyelid conditions without sending patients elsewhere, which improves continuity of care.
Potential for additional reimbursement
When the case is medically necessary and documented properly, these procedures may be billable to insurance, which can help offset equipment and time investment.
How Derma Cautery fits in
The Derma Cautery™ system was built specifically to help trained eye care professionals perform in-office lesion removal in a consistent, controlled way.
With proper training and patient selection, it can be integrated into a typical exam flow without significantly disrupting workflow.
You can learn more about the Dermacautery training and treatment system and how it fits into your practice.
A quick note on insurance, billing, and scope of practice
Insurance coverage, coding rules, and scope of practice can vary quite a bit depending on the payer and the state.
Practices should always confirm current requirements before billing and ensure documentation supports the clinical decision-making behind the procedure.